Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue
04/09/2026 12:08
BRIEF-Kdventures' Modus Therapeutics Carries Out Directed Issue Sept 4 (Reuters) - Kdventures AB KDV.ST:
KDVENTURES AB - KDVENTURES PORTFOLIO COMPANY MODUS THERAPEUTICS CARRIES OUT A DIRECTED ISSUE OF MSEK 7.6
KDVENTURES AB - DIRECTED ISSUE OF 20,000,000 SHARES WAS SUBSCRIBED AT A PRICE OF SEK 0.38 PER SHARE
Source text: ID:nMFN7KhW9z
Further company coverage: KDV.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue